Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $15.7700 (0.32%) ($15.7700 - $15.7700) on Tue. Apr. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.98% (three month average) | RSI | 32 | Latest Price | $15.7700(0.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(62%) IWC(61%) IBUY(60%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.49% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-10%) TBT(-10%) UNG(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.49% (StdDev 4.98%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $18.61 | 5 Day Moving Average | $16.95(-6.96%) | 10 Day Moving Average | $17.89(-11.85%) | 20 Day Moving Average | $18.61(-15.26%) | To recent high | -26% | To recent low | 11.8% | Market Cap | $979m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |